Skip to main content

CORRECTION article

Front. Cell Dev. Biol., 03 July 2023
Sec. Cancer Cell Biology

Corrigendum: METTL3 contributes to osteosarcoma progression by increasing DANCR mRNA stability via m6A modification

Xinying ZhouXinying Zhou1Yang YangYang Yang1Yuejun LiYuejun Li1Guojun LiangGuojun Liang1Dawei KangDawei Kang1Bing Zhou
Bing Zhou2*Qingchu Li
Qingchu Li1*
  • 1Department of Spine Surgery, Center for Orthopaedic Surgery, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China
  • 2Department of Orthopedics, Longtan Hospital of Guangxi Autonomous Region, Liuzhou, China

A Corrigendum on
METTL3 contributes to osteosarcoma progression by increasing DANCR mRNA stability via m6A modification

by Zhou X, Yang Y, Li Y, Liang G, Kang D, Zhou B and Li Q (2022) Front. Cell Dev. Biol. 9:784719. doi: 10.3389/fcell.2021.784719

In the published article, there was an error in Figure 4 as published. The corrected Figure 4 and its caption appear below.

FIGURE 4
www.frontiersin.org

FIGURE 4. The METTL3/lncRNA DANCR axis promotes OS cell tumorigenesis and progression. (A) Correlations between METTL3 and DANCR expression in OS tissue (n = 40). (B) RT-qPCR showing increased DANCR levels in OS tumor tissues when compared with matched normal tissues. (C) Kaplan–Meier survival analyses of patients with OS. Patients with higher DANCR levels showed a relatively poor prognosis. (D) RT-qPCR showing elevated DANCR expression in Saos-2, SJSA-1, MG63, HOS, and U-2 OS cells compared with human fetal osteoblastic cells. CCK-8 assays were used to determine viability in HOS (E) and U-2 OS (F) cells transfected with si-DANCR or the corresponding control. Transwell assays were used to assess the migration activities of HOS and U-2 OS cells. (G) Quantitative analyses of migrating cells passing through membranes without Matrigel. (H) Representative images of OS cell migration. Transwell assays were used to examine the invasion activities of HOS and U-2 OS cells. (I) Quantitative analyses of migrating cells passing through membranes plus Matrigel. (J) Representative images of OS cell invasion. (K, L) Relative METTL3 expression with or without si-DANCR infected. *p < 0.05.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: osteosarcoma, m6A modification, METTL3, lncRNA DANCR, mRNA stability

Citation: Zhou X, Yang Y, Li Y, Liang G, Kang D, Zhou B and Li Q (2023) Corrigendum: METTL3 contributes to osteosarcoma progression by increasing DANCR mRNA stability via m6A modification. Front. Cell Dev. Biol. 11:1167476. doi: 10.3389/fcell.2023.1167476

Received: 16 February 2023; Accepted: 16 June 2023;
Published: 03 July 2023.

Edited and reviewed by:

Birija Sankar Patro, Bhabha Atomic Research Centre (BARC), India

Copyright © 2023 Zhou, Yang, Li, Liang, Kang, Zhou and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Bing Zhou, 747238709@qq.com; Qingchu Li, lqc16@263.net

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.